Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.97% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
Business First Bancshares
BFST
$1.05B
| $416K | ﹤0.01% |
16,200
+1,300
| +9% | +$34.9K |
|
2927
Motorcar Parts of America
MPAA
$230M
| $415K | ﹤0.01% |
54,600
-18,400
| -25% | -$125K |
|
2928
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.92B
| $414K | ﹤0.01% |
+2,200
| New | +$428K |
|
2929
Direxion Daily TSLA Bear 1X ETF
TSLS
$73.8M
| $414K | ﹤0.01% |
+5,140
| New | +$599K |
|
2930
Trevi Therapeutics
TRVI
$2.53B
| $414K | ﹤0.01% |
100,400
+29,700
| +42% | +$95.1K |
|
2931
Enpro
NPO
$7.12B
| $414K | ﹤0.01% |
2,398
-14,802
| -86% | -$2.5M |
|
2932
US Global Investors
GROW
$38.7M
| $413K | ﹤0.01% |
169,202
-1,358
| -0.8% | -$3.33K |
|
|
WMPN
2933
DELISTED
William Penn Bancorporation Common Stock
WMPN
| $413K | ﹤0.01% |
34,400
+15,200
| +79% | +$193K |
|
2934
Pathward Financial
CASH
$1.78B
| $412K | ﹤0.01% |
+5,600
| New | +$427K |
|
2935
Kforce
KFRC
$1.03B
| $411K | ﹤0.01% |
7,249
-42,500
| -85% | -$2.47M |
|
|
NEWP
2936
New Pacific Metals
NEWP
$1.22B
| $409K | ﹤0.01% |
346,300
+23,600
| +7% | +$36.8K |
|
|
OKUR
2937
OnKure Therapeutics
OKUR
$159M
| $408K | ﹤0.01% |
47,450
-2,703
| -5% | -$40.9K |
|
2938
Biglari Holdings Class A
BH.A
$1.23B
| $408K | ﹤0.01% |
320
-30
| -9% | -$31.7K |
|
|
PARAA
2939
DELISTED
Paramount Global Class A
PARAA
| $407K | ﹤0.01% |
18,266
-6,200
| -25% | -$138K |
|
2940
GEN Restaurant Group
GENK
$10.3M
| $407K | ﹤0.01% |
54,400
+38,200
| +236% | +$318K |
|
2941
Spruce Power Holding Corp
SPRU
$38.9M
| $406K | ﹤0.01% |
136,820
+1,000
| +0.7% | +$2.62K |
|
2942
NBT Bancorp
NBTB
$2.78B
| $406K | ﹤0.01% |
8,500
-20,339
| -71% | -$968K |
|
2943
Pyxis Tankers
PXS
$50.9M
| $406K | ﹤0.01% |
103,201
-30,100
| -23% | -$127K |
|
2944
State Street SPDR Dow Jones REIT ETF
RWR
$1.89B
| $405K | ﹤0.01% |
4,100
-8,800
| -68% | -$916K |
|
2945
Pacer Global Cash Cows Dividend ETF
GCOW
$3.48B
| $405K | ﹤0.01% |
+12,000
| New | +$422K |
|
2946
Tyra Biosciences
TYRA
$1.49B
| $404K | ﹤0.01% |
+29,100
| New | +$528K |
|
2947
Compass Therapeutics
CMPX
$407M
| $404K | ﹤0.01% |
278,600
+56,000
| +25% | +$93K |
|
2948
Helmerich & Payne
HP
$4.29B
| $403K | ﹤0.01% |
12,600
-228,601
| -95% | -$7.76M |
|
2949
Mammoth Energy Services
TUSK
$158M
| $401K | ﹤0.01% |
133,572
-100
| -0.1% | -$368 |
|
2950
NextCure
NXTC
$37.9M
| $400K | ﹤0.01% |
43,275
+9,442
| +28% | +$139K |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.